Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Critical Pathways × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pituitary Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Magnetic Resonance Spectroscopy 12 Watchful Waiting 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Standard of Care 4 Patient Reported Outcome Measures 4 Palliative Care 4 Neoadjuvant Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02965794 2020-01-28

CP4GICAN

European Pathway Association

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡